Progressive postresection program (pPRP) after pancreatic resection: study protocol for a randomized controlled trial

BACKGROUND: At the time of initial diagnosis, only 15–20 % of patients with pancreatic cancer present with a resectable disease. Patients with pancreatic cancer face a poor prognosis. Progression-free survival and overall survival rates are very limited, so it is important to develop concepts to imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Susanne, Uslar, Verena, Tabriz, Navid, Mueser, Thomas, Weyhe, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750352/
https://www.ncbi.nlm.nih.gov/pubmed/26863867
http://dx.doi.org/10.1186/s13063-016-1200-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750352/
https://www.ncbi.nlm.nih.gov/pubmed/26863867
http://dx.doi.org/10.1186/s13063-016-1200-0

Ejemplares similares